RxDoctor Payments Data

Sydnee Nelson, MD

Family Medicine · Council Grove, KSNPI 1356802003

Payments from drug & device makers

$619in general payments, 2019–2025

Across 36 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$91
  • Novartis$68
  • Pfizer$62
  • Novo Nordisk$59
  • Boehringer Ingelheim$57
  • Mylan Specialty L.p.$43
  • plus $240 from 10 others

What the payments were for

  • Food & beverage$619100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$619 in reported general payments places this provider in the 55th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$13,511
Medicare patients
27
Services billed
163

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin63$53,279
EliquisApixaban48$48,236
MounjaroTirzepatide24$28,818
XareltoRivaroxaban32$22,195
OzempicSemaglutide14$20,664
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,758
Tresiba Flextouch U-100Insulin Degludec13$6,834
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$6,368
Aripiprazole25$6,360
TradjentaLinagliptin19$5,269
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$5,030
Fluvoxamine Maleate ErFluvoxamine Maleate13$4,751
Varenicline Tartrate13$4,345
Potassium Chloride136$2,770
Levothyroxine Sodium214$2,477

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$57$58,54882 claims
PfizerEliquis$62$48,23648 claims
Lilly USA, LLCMounjaro$30$28,81824 claims
Novo NordiskOzempic$59$20,66414 claims
AbbVieSynthroid$18$1,18042 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Council Grove

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →